VENABLE LLP

Lobbying for DRUGS FOR NEGLECTED DISEASES INITIATIVE NORTH AMERICA · Non-profit product development partnership

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New York · $10,000.00 income · posted Jan 5, 2026

Lobbying activity 1

Budget/Appropriations

FY 2026 Labor, Health and Human Services, Education and State and Foreign Operations funding for global health research and development and neglected tropical diseases FY 2026 global health research and development funding Issues related to global health

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.